Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 201 - 300
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
201 | 25099229 |
US |
||
Dry skin, |
||||
ISOTRETINOIN, |
||||
202 | 25099253 |
US |
29 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
203 | 25099291 |
US |
61 | 2 |
Haemoptysis, Hypertension, Headache, Dehydration, Abdominal pain, Fatigue, Weight increased, Arthralgia, Palmar-plantar erythrodysaesthesia syndrome, Dry skin, Stomatitis, Urticaria, Vomiting, Nausea, Diarrhoea, Dysphonia, Hyperacusis, Tinnitus, Weight decreased, |
||||
LENVATINIB, LENVATINIB, |
||||
204 | 25099360 |
US |
||
Dry skin, |
||||
ADAPALENE, ADAPLANE 0.1%, |
||||
205 | 25099363 |
US |
1 | |
Dry skin, |
||||
ADAPALENE, ADAPLANE 0.1%, |
||||
206 | 25099562 |
US |
42 | 2 |
Dry skin, Pruritus, Drug dose omission by device, Device operational issue, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
207 | 25099703 |
US |
2 | |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
208 | 25099723 |
US |
80 | 1 |
Eczema, Middle insomnia, Dry skin, Skin fissures, Pruritus, Skin exfoliation, Scratch, |
||||
DUPILUMAB, APIXABAN, |
||||
209 | 25099882 |
BR |
52 | 2 |
Metastases to bone, Spinal deformity, Decreased immune responsiveness, Lip dry, Dry throat, Sluggishness, Throat clearing, Vulvovaginal dryness, Visual impairment, Concomitant disease aggravated, Atrophy, Gait inability, Illness, Intervertebral disc protrusion, Dry skin, Platelet count decreased, Nausea, Cough, Nausea, Asthenia, Eating disorder, Weight increased, Muscle spasms, Hypoaesthesia, Limb discomfort, Insomnia, Adverse drug reaction, Anxiety, Decreased appetite, Weight decreased, Decreased immune responsiveness, Fear, Pain in extremity, Bone pain, Vomiting, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
210 | 25100618 |
US |
70 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
211 | 25100891 |
US |
15 | 1 |
Dry skin, Ocular hyperaemia, |
||||
DUPILUMAB, |
||||
212 | 25100945 |
US |
||
Dry skin, Skin exfoliation, |
||||
NEMOLIZUMAB-ILTO, |
||||
213 | 25100998 |
US |
||
Abdominal pain upper, Dry skin, |
||||
NEMOLIZUMAB-ILTO, |
||||
214 | 25101041 |
US |
||
Pruritus, Dry skin, |
||||
NEMOLIZUMAB-ILTO, VENLAFAXINE HYDROCHLORIDE, ERGOCALCIFEROL, PROGESTERONE, SUMATRIPTAN, ESZOPICLONE, MODAFINIL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
215 | 25101047 |
US |
||
Dry skin, Sensitive skin, |
||||
NEMOLIZUMAB-ILTO, |
||||
216 | 25101164 |
US |
46 | 1 |
Lip dry, Condition aggravated, Dry skin, Dry eye, |
||||
DUPILUMAB, |
||||
217 | 25101193 |
US |
||
Skin exfoliation, Dry skin, Erythema, Eczema, Eczema nummular, |
||||
NEMOLIZUMAB-ILTO, |
||||
218 | 25092174 |
US |
86 | 2 |
Pruritus, Dry skin, Injection site pain, Dry eye, |
||||
DUPILUMAB, |
||||
219 | 25092179 |
US |
4 | 2 |
Erythema, Dry skin, Perioral dermatitis, Rash, |
||||
DUPILUMAB, |
||||
220 | 25092394 |
US |
2 | |
Nasal congestion, Rhinorrhoea, Peripheral swelling, Pruritus, Dry throat, Aphonia, Insomnia, Dry skin, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FAMOTIDINE, CALCIUM, |
||||
221 | 25092523 |
US |
86 | 2 |
Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, ALPRAZOLAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, GABAPENTIN, ATENOLOL, |
||||
222 | 25092583 |
US |
1 | |
Product dose omission issue, Skin disorder, Malaise, Alopecia, Skin atrophy, Pruritus, Weight decreased, Dry skin, Joint swelling, Rash, Exercise tolerance decreased, |
||||
RIVAROXABAN, |
||||
223 | 25092708 |
US |
2 | |
Supraventricular tachycardia, Palpitations, Dysphonia, Dry skin, Rash, Inflammation, Nausea, Pruritus, Injection site pain, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
224 | 25092732 |
US |
3 | 1 |
Pruritus, Middle insomnia, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
225 | 25092810 |
US |
18 | 1 |
Skin fissures, Dry skin, |
||||
DUPILUMAB, |
||||
226 | 25092899 |
US |
2 | |
Skin burning sensation, Blister, Dermatitis atopic, Bone pain, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
227 | 25093041 |
JP |
75 | 1 |
Neuropathy peripheral, Deep vein thrombosis, Hypomagnesaemia, Dermatitis acneiform, Paronychia, Dry skin, Diarrhoea, |
||||
PANITUMUMAB, PANITUMUMAB, FLUOROURACIL, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, OXALIPLATIN, |
||||
228 | 25093346 |
GB |
46 | 1 |
Sexual dysfunction, Emotional disorder, Cognitive disorder, Muscle atrophy, Suicidal ideation, Dry skin, Product use in unapproved indication, |
||||
MIRTAZAPINE, |
||||
229 | 25093666 |
US |
2 | |
Dry skin, Erythema of eyelid, Eyelid irritation, Eyelids pruritus, Eyelid skin dryness, Lip dry, Swelling of eyelid, |
||||
BUPROPION HYDROCHLORIDE, |
||||
230 | 25093747 |
US |
2 | |
Dermatitis atopic, Dry skin, Skin fissures, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
231 | 25093783 |
US |
2 | |
Dry skin, Arthralgia, |
||||
DUPILUMAB, ATOMOXETINE, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, EXEMESTANE, FENOFIBRATE, ROSUVASTATIN, TIZANIDINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
232 | 25093791 |
US |
26 | 2 |
Dry skin, Dermatitis atopic, Therapeutic response shortened, Skin fissures, Skin haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, |
||||
233 | 25094021 |
US |
56 | 2 |
Lacrimation increased, Eyelid skin dryness, Dry skin, Eye pruritus, Oral herpes, |
||||
DUPILUMAB, |
||||
234 | 25094094 |
US |
26 | 2 |
Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
235 | 25094102 |
US |
19 | 2 |
Haemorrhage, Erythema, Condition aggravated, Dry skin, Dry eye, Pruritus, Eye pruritus, Ocular hyperaemia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
236 | 25094818 |
CN |
50 | 1 |
Hypersensitivity, Oedema, Eyelid disorder, Visual impairment, Ocular discomfort, Pallor, Skin turgor decreased, Dry skin, Skin fragility, |
||||
237 | 25094954 |
TH |
79 | 1 |
Pain in extremity, Gait inability, Musculoskeletal stiffness, Fatigue, Product use issue, Hypersensitivity, Skin fissures, Dry skin, Peripheral swelling, Erythema, |
||||
REGORAFENIB, REGORAFENIB, |
||||
238 | 25094955 |
US |
34 | 1 |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
239 | 25094956 |
US |
49 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
240 | 25095153 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
241 | 25095154 |
US |
||
Dry skin, |
||||
242 | 25095157 |
US |
||
Dry skin, Skin irritation, Acne, Skin burning sensation, Rash, |
||||
ADAPALENE, |
||||
243 | 25095168 |
US |
||
Skin burning sensation, Skin irritation, Condition aggravated, Dry skin, |
||||
ADAPALENE, |
||||
244 | 25095169 |
US |
||
Acne, Dry skin, |
||||
ADAPALENE, BENZOYL PEROXIDE, |
||||
245 | 25095179 |
US |
||
Dry skin, Skin burning sensation, Pain of skin, Erythema, |
||||
ADAPALENE, |
||||
246 | 25095181 |
US |
||
Skin burning sensation, Dry skin, Skin irritation, Expired product administered, |
||||
ADAPALENE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
247 | 25095191 |
US |
||
Photosensitivity reaction, Skin exfoliation, Dry skin, Erythema, Acne, |
||||
248 | 25095196 |
US |
||
Dry skin, Rash macular, |
||||
ADAPALENE, |
||||
249 | 25095197 |
US |
||
Skin burning sensation, Skin discomfort, Dry skin, Rash, |
||||
ADAPALENE, ADAPALENE, |
||||
250 | 25095199 |
US |
||
Dry skin, Drug ineffective, |
||||
ADAPALENE, |
||||
251 | 25095200 |
US |
||
Dry skin, Eczema, |
||||
ADAPALENE, |
||||
252 | 25095205 |
US |
||
Dry skin, Pain of skin, |
||||
ADAPALENE, |
||||
253 | 25095209 |
US |
||
Dry skin, Erythema, |
||||
ADAPALENE, |
||||
254 | 25095217 |
US |
||
Dry skin, Drug ineffective, |
||||
ADAPALENE, |
||||
255 | 25095221 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
256 | 25095241 |
US |
||
Erythema, Dry skin, Skin burning sensation, Acne, Product use issue, |
||||
ADAPALENE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
257 | 25095245 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
258 | 25095248 |
US |
||
Skin irritation, Acne, Dry skin, |
||||
ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, |
||||
259 | 25095259 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin exfoliation, Pain of skin, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, |
||||
260 | 25095260 |
US |
||
Dry skin, Acne, Erythema, Pain of skin, Skin fissures, Drug ineffective, |
||||
ADAPALENE, |
||||
261 | 25095265 |
US |
||
Condition aggravated, Dry skin, Skin fissures, |
||||
ADAPALENE, |
||||
262 | 25095277 |
US |
||
Purulent discharge, Cheilitis, Lip scab, Lip dry, Scab, Dry skin, Pruritus, Skin swelling, Rash, |
||||
BENZOYL PEROXIDE, ADAPALENE, |
||||
263 | 25095632 |
US |
2 | |
Weight increased, Abdominal discomfort, Pain, Feeling abnormal, Multiple allergies, Sinus headache, Muscular weakness, Musculoskeletal stiffness, Dry skin, Dysphonia, Exercise tolerance decreased, Vitamin D decreased, Vision blurred, Abdominal pain upper, Flushing, Feeling hot, Peroneal nerve palsy, Gait disturbance, Dizziness, Back pain, |
||||
DALFAMPRIDINE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, BACLOFEN, LEVONORGESTREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM, OIL, BIOTIN, HAIR, CETIRIZINE HYDROCHLORIDE, |
||||
264 | 25095712 |
US |
38 | 1 |
Dry skin, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
265 | 25095771 |
US |
49 | 2 |
Dry skin, Skin exfoliation, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
266 | 25095824 |
US |
2 | |
Dry skin, Dermatitis atopic, |
||||
DUPILUMAB, LEVONORGESTREL, |
||||
267 | 25095865 |
US |
||
Dry skin, Off label use, |
||||
TRETINOIN, |
||||
268 | 25095866 |
US |
||
Dry skin, Product use in unapproved indication, |
||||
TRETINOIN, |
||||
269 | 25095867 |
US |
||
Dry skin, |
||||
TRETINOIN, |
||||
270 | 25095869 |
US |
||
Dry skin, Skin tightness, Off label use, |
||||
TRETINOIN, |
||||
271 | 25095871 |
US |
||
Dry skin, Off label use, Skin exfoliation, |
||||
TRETINOIN, ACYCLOVIR, AMLODIPINE, LORATADINE, LORATADINE TABLET, |
||||
272 | 25095962 |
US |
2 | |
Dry skin, |
||||
EFINACONAZOLE, |
||||
273 | 25096111 |
PT |
76 | 1 |
Neuropathy peripheral, Neutropenia, Acute kidney injury, Respiratory failure, Cardiac failure, Rectal haemorrhage, Haemorrhoidal haemorrhage, Atrial fibrillation, Hyperglycaemia, Dry skin, Skin exfoliation, Erythema, Decreased appetite, Weight decreased, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, APIXABAN, BISOPROLOL FUMARATE, ROSUVASTATIN, |
||||
274 | 25096362 |
US |
67 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
275 | 25096373 |
CN |
54 | 2 |
Eczema, Skin ulcer, Erythema, Papule, Hyperkeratosis, Skin fissures, Dry skin, Skin weeping, |
||||
SECUKINUMAB, |
||||
276 | 25096536 |
US |
4 | 2 |
Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
277 | 25096552 |
US |
3 | 2 |
Dry skin, Skin exfoliation, Eye pruritus, |
||||
DUPILUMAB, HYDROXYZINE, MOMETASONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DESONIDE, |
||||
278 | 25096745 |
US |
33 | 1 |
Eczema, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
279 | 25087120 |
US |
76 | 2 |
Dry skin, Pruritus, |
||||
ADALIMUMAB, ETANERCEPT, |
||||
280 | 25087663 |
US |
64 | 2 |
Subarachnoid haemorrhage, Off label use, Pain, Tremor, Illness, Epistaxis, Dry skin, Alopecia, Rash, Arthralgia, Hypersomnia, Ill-defined disorder, Pain, |
||||
TRASTUZUMAB, TRASTUZUMAB, PACLITAXEL, |
||||
281 | 25087816 |
US |
68 | 1 |
Abdominal discomfort, Dry skin, Haemorrhage, Discharge, Eye irritation, Skin exfoliation, Dry skin, Balance disorder, Agitation, Sleep disorder, Pruritus, Skin fissures, |
||||
TRALOKINUMAB-LDRM, VALACYCLOVIR HYDROCHLORIDE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
282 | 25088219 |
US |
64 | 2 |
Dry skin, Hair texture abnormal, Nail disorder, Fatigue, |
||||
ABATACEPT, |
||||
283 | 25088239 |
US |
||
Condition aggravated, Pain of skin, Dry skin, |
||||
ISOTRETINOIN, |
||||
284 | 25089432 |
US |
1 | |
Cellulitis staphylococcal, Cellulitis, Rash, Dry skin, External ear cellulitis, |
||||
LEVOTHYROXINE SODIUM, CANNABIDIOL, |
||||
285 | 25089612 |
US |
60 | 2 |
Pain, Dry mouth, Oral pain, Dry skin, Pruritus, Headache, Product dose omission issue, |
||||
FEDRATINIB HYDROCHLORIDE, |
||||
286 | 25089634 |
CN |
28 | 1 |
Teratogenicity, Dry skin, Therapeutic product effect incomplete, |
||||
ACITRETIN, |
||||
287 | 25090604 |
US |
2 | |
Diabetes mellitus, Scab, Dry skin, |
||||
DUPILUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PREGABALIN, ROSUVASTATIN CALCIUM, ESCITALOPRAM OXALATE, ESCITALOPRAM, BUPROPION HYDROCHLORIDE, BUPROPION, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, INSULIN GLARGINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, ROSUVASTATIN, LEVOTHYROXINE SODIUM, LOSARTAN, DOXEPIN, DOXEPIN HYDROCHLORIDE, INSULIN LISPRO, |
||||
288 | 25091424 |
US |
42 | 1 |
Sleep disorder due to a general medical condition, Rebound atopic dermatitis, Dry skin, Acne, Pruritus, Diarrhoea, Gastrointestinal sounds abnormal, Vomiting, Urticaria, Inappropriate schedule of product administration, |
||||
DUPILUMAB, LEBRIKIZUMAB-LBKZ, |
||||
289 | 25091481 |
US |
5 | 2 |
Swelling face, Dry skin, Rash, Rash pruritic, Skin fissures, |
||||
DUPILUMAB, |
||||
290 | 25091496 |
US |
27 | 2 |
Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
291 | 25091518 |
US |
39 | 2 |
Eczema, Dry skin, Pruritus, Inflammation, |
||||
DUPILUMAB, |
||||
292 | 25091562 |
US |
59 | 2 |
Dry skin, Scratch, Injection site pain, |
||||
DUPILUMAB, PRAVASTATIN SODIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, LISINOPRIL, |
||||
293 | 25091566 |
US |
79 | 1 |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
294 | 25091567 |
US |
67 | 1 |
Blood pressure abnormal, Rash macular, Dry skin, Haemorrhage, Skin exfoliation, Pruritus, Dizziness, Endodontic procedure, Product dose omission in error, |
||||
DUPILUMAB, APIXABAN, LISINOPRIL, |
||||
295 | 25091569 |
US |
16 | 1 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
296 | 25091589 |
US |
80 | 2 |
Dry skin, Skin exfoliation, Urinary tract infection, |
||||
DUPILUMAB, |
||||
297 | 25091593 |
US |
72 | 2 |
Adrenal disorder, Eczema, Dry skin, |
||||
DUPILUMAB, |
||||
298 | 25091601 |
US |
33 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
299 | 25091606 |
US |
40 | 1 |
Dry skin, Skin irritation, Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, OATMEAL, CETIRIZINE HYDROCHLORIDE, |
||||
300 | 25091651 |
US |
5 | 2 |
Dry skin, Headache, |
||||
DUPILUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28